Cosmos Health: Bovopoulos reports about 6.89% stake

The reported position carries sole voting and dispositive power, while shared voting and dispositive power are listed as zero.

Rhea-AI Filing Summary

Cosmos Health Inc. is the issuer named in an amended beneficial-ownership report stating that individual investor Andreas Bovopoulos beneficially owned 6,930,412 shares of common stock, approximately 6.887% of the class. The report lists sole voting and dispositive power over the position and zero shared voting or dispositive power. The percentage calculation uses 100,633,773 shares outstanding, as reported in Cosmos Health’s Form 10-Q for the quarter ended June 30, 2026.

Key Figures

Beneficially owned: 6,930,412 shares Ownership percentage: Approximately 6.887% Sole voting power: 6,930,412 shares +2 more

5 metrics

Beneficially owned 6,930,412 shares Andreas Bovopoulos's reported position

Ownership percentage Approximately 6.887% Percentage of the class

Sole voting power 6,930,412 shares Andreas Bovopoulos's reported power

Sole dispositive power 6,930,412 shares Andreas Bovopoulos's reported power

Shares outstanding 100,633,773 shares Reported for the quarter ended June 30, 2026

Key Terms

beneficial ownership, Sole Voting Power, Sole Dispositive Power

3 terms

beneficial ownership financial

"Amount beneficially owned"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

Sole Voting Power financial

"Sole power to vote or to direct the vote"

Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.

Sole Dispositive Power financial

"Sole power to dispose or to direct the disposition"

Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many COSM shares does Andreas Bovopoulos beneficially own?

Andreas Bovopoulos beneficially owned 6,930,412 shares of Cosmos Health common stock, approximately 6.887% of the class.

Does Andreas Bovopoulos have sole voting power over COSM shares?

The report lists sole voting and dispositive power over 6,930,412 shares, with shared voting and dispositive power of zero.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/30/2026 - 04:06 PM EDT Accepted by SEC EDGAR 10/30/2026 - 04:05 PM EDT Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 6)

Cosmos Health Inc.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

221413206

(CUSIP Number)

10/30/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 221413206

1

Names of Reporting Persons

Bovopoulos Andreas

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

CALIFORNIA

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 6,930,412.30
6	Shared Voting Power 0.00
7	Sole Dispositive Power 6,930,412.30
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

6,930,412.30

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

6.9 %

12

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Cosmos Health Inc.
(b)	Address of issuer's principal executive offices: 5 AGIOU GEORGIOU, PILEA, THESSALONIKI, GREECE, 55438
Item 2.
(a)	Name of person filing: Andreas Bovopoulos
(b)	Address or principal business office or, if none, residence: 15413 Lone Hill Road Los Gatos, CA 95032 USA
(c)	Citizenship: USA
(d)	Title of class of securities: Common Stock
(e)	CUSIP No.: 221413206
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 6930412.30
(b)	Percent of class: 6.887% Ownership Percentage Calculation: The reported beneficial ownership of 6,930,412.30 shares represents approximately 6.887% of the 100,633,773 shares outstanding, as reported by Cosmos Health Inc. in its Form 10-Q for the quarterly period ended June 30, 2026.
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 6930412.30
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 6930412.30
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Bovopoulos Andreas

Signature:	Andreas Bovopoulos
Name/Title:	Individual Investor
Date:	10/30/2026